AbL Diagnostics SA Capital Reinvestment Ratio
AbL Diagnostics SA capital reinvestment ratio. AbL Diagnostics SA (ABLD) has a Capital Reinvestment Ratio of 0.84x as of June 2025, meaning it reinvests 1% of its operating cash flow (€479.46K) in capital expenditures (€400.39K). Check AbL Diagnostics SA (ABLD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AbL Diagnostics SA (2017–2025)
Capital reinvestment ratio of AbL Diagnostics SA from 2017 to 2025. This chart tracks AbL Diagnostics SA's Capital Reinvestment Ratio across 4 annual periods. Also explore AbL Diagnostics SA equity growth rate to track the company's year-over-year net asset growth rate.
AbL Diagnostics SA Capital Reinvestment Ratio by Year (2017–2025)
AbL Diagnostics SA capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see ABLD operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €926.43K | €938.50K | ▼ -87.3% |
| 2018 | 7.95x | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €675.20K | €305.02K | — |